youngae kang

Department of Internal Medicine

EmailMDKANG@YUHS.AC

2114 Citations
23 h-Index

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where youngae kang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Tuberculosis Medicine & Life Sciences

Korea Medicine & Life Sciences

Lung Medicine & Life Sciences

Latent Tuberculosis Medicine & Life Sciences

Tuberculin Test Medicine & Life Sciences

Multidrug-Resistant Tuberculosis Medicine & Life Sciences

Pneumonia Medicine & Life Sciences

Skin Tests Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

2114 Citations
23 h-Index
125 Article
4 Review article
2 Comment/debate
1 Editorial

1 Citation (Scopus)

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): Study protocol for a phase II/III, multicenter, randomized, open-label clinical trial

Lee, M., Mok, J., Kim, D. K., Shim, T. S., Koh, W. J., Jeon, D., Lee, T., Lee, S. H., Kim, J. S., Park, J. S., Lee, J. Y., Kim, S. Y., Lee, J. H., Jo, K. W., Jhun, B. W., kang, Y., Ahn, J. H., Kim, C. K., Shin, S., Song, T. & 8 others, Shin, S., Kim, Y. R., Ahn, H., Hahn, S., Won, H. J., Jang, J. Y., Cho, S. N. & Yim, J. J., 2019 Jan 16, In : Trials. 20, 1, 57.

Research output: Contribution to journal › Article

Open Access

Linezolid

Pyrazinamide

Multidrug-Resistant Tuberculosis

Levofloxacin

Fluoroquinolones

Improved Fluoroquinolone-Resistant and Extensively Drug-Resistant Tuberculosis Treatment Outcomes

Lee, E. H., Yong, S. H., Leem, A. Y., Lee, S. H., Kim, S. Y., Chung, K. S., Jung, J. Y., Park, M. S., Kim, Y. S., Chang, J. & kang, Y., 2019 Apr 1, In : Open Forum Infectious Diseases. 6, 4

Research output: Contribution to journal › Article

Open Access

Extensively Drug-Resistant Tuberculosis

Multidrug-Resistant Tuberculosis

Fluoroquinolones

Linezolid

bedaquiline

In vitro mycobacterial growth inhibition in South Korean adults with latent TB infection

Lee, H., Kim, J., kang, Y., Kim, D. R., Sim, B., Zelmer, A., Fletcher, H. A., Dockrell, H. M., Smith, S. G. & Cho, S., 2019 Jan 1, In : Frontiers in Immunology. 10, APR, 896.

Research output: Contribution to journal › Article

Open Access

Growth

Infection

Bacillus

Mycobacterium Infections

Staining and Labeling

Prevalence, incidence, and mortality of nontuberculous mycobacterial infection in Korea: a nationwide population-based study

Park, S. C., Kang, M. J., Han, C. H., Lee, S. M., Kim, C. J., Lee, J. M. & kang, Y., 2019 Aug 1, In : BMC pulmonary medicine. 19, 1, 1 p.

Research output: Contribution to journal › Article

Open Access

Korea

Mortality

Incidence

Infection

Population

Prognosis of Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: Assessment according to GAP Stage

Song, M. J., Lim, S. Y., Park, J. S., Yoon, H. I., Lee, J. H., Kim, S. Y., Jung, J. Y., kang, Y., Park, M. S., Kim, Y. S., Chang, J., Lee, S. H. & Lee, C. T., 2019 Jan 1, In : Journal of Oncology. 2019, 5437390.

Research output: Contribution to journal › Article

Open Access

Idiopathic Pulmonary Fibrosis

Small Cell Lung Carcinoma

Survival

Lung Neoplasms

Republic of Korea